Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Brain
    August 2021
  1. KHAN AR, Ottoy J, Goubran M
    Towards a comprehensive 3D mapping of tau progression in early Alzheimer's disease.
    Brain. 2021 Aug 23. pii: 6356553. doi: 10.1093.
    >> Share

  2. DAVILA-BOUZIGUET E, Casoliba-Melich A, Targa-Fabra G, Galera-Lopez L, et al
    Functional protection in J20/VLW mice: a model of non-demented with Alzheimer's disease neuropathology.
    Brain. 2021 Aug 23. pii: 6356505. doi: 10.1093.
    >> Share

  3. STROM A, Iaccarino L, Edwards L, Lesman-Segev OH, et al
    Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
    Brain. 2021 Aug 9. pii: 6346980. doi: 10.1093.
    >> Share

    July 2021
  4. PAUMIER A, Boisseau S, Jacquier-Sarlin M, Pernet-Gallay K, et al
    Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade.
    Brain. 2021 Jul 24. pii: 6327685. doi: 10.1093.
    >> Share

  5. GOURMAUD S, Stewart DA, Irwin DJ, Roberts N, et al
    The role of mTORC1 activation in seizure-induced exacerbation of Alzheimer's disease.
    Brain. 2021 Jul 15. pii: 6321945. doi: 10.1093.
    >> Share

  6. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Corrigendum to: Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321152. doi: 10.1093.
    >> Share

  7. PEREIRA JB, Janelidze S, Smith R, Mattsson-Carlgren N, et al
    Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease.
    Brain. 2021 Jul 14. pii: 6321226. doi: 10.1093.
    >> Share

  8. BAILES SM, Lewis LD
    Distinct cardiac-locked brain pulsations in Alzheimer's disease.
    Brain. 2021 Jul 9. pii: 6318392. doi: 10.1093.
    >> Share

  9. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    Corrigendum to: CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2021 Jul 3. pii: 6313379. doi: 10.1093.
    >> Share

    June 2021
  10. MATTHEWS DC, Mao X, Dowd K, Tsakanikas D, et al
    Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
    Brain. 2021 Jun 18. pii: 6305835. doi: 10.1093.
    >> Share

  11. PATEL AG, Nehete PN, Krivoshik SR, Pei X, et al
    Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
    Brain. 2021 Jun 15. pii: 6297373. doi: 10.1093.
    >> Share

  12. SCHUMACHER J, Gunter JL, Przybelski SA, Jones DT, et al
    Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Brain. 2021 Jun 11. pii: 6296589. doi: 10.1093.
    >> Share

    May 2021

  13. Erratum to: The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2021 May 23. pii: 6282423. doi: 10.1093.
    >> Share

  14. DEHGHANI N, Bras J, Guerreiro R
    Erratum to: How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 May 20. pii: 6279241. doi: 10.1093.
    >> Share

    April 2021
  15. O'CONNOR A, Pannee J, Poole T, Arber C, et al
    Plasma amyloid-beta ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
    Brain. 2021 Apr 23. pii: 6248083. doi: 10.1093.
    >> Share

  16. DEHGHANI N, Bras J, Guerreiro R
    How understudied populations have contributed to our understanding of Alzheimer's disease genetics.
    Brain. 2021 Apr 23. pii: 6247156. doi: 10.1093.
    >> Share

  17. YAO Y, Kang SS, Xia Y, Wang ZH, et al
    A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
    Brain. 2021 Apr 20. pii: 6242262. doi: 10.1093.
    >> Share


  18. Erratum to: Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2021 Apr 20. pii: 6238673. doi: 10.1093.
    >> Share

  19. OZAWA S, Hori Y, Shimizu Y, Taniguchi A, et al
    Photo-oxygenation by a biocompatible catalyst reduces amyloid-beta levels in Alzheimer's disease mice.
    Brain. 2021 Apr 14. pii: 6224831. doi: 10.1093.
    >> Share

  20. TOME SO, Thal DR
    Co-pathologies in Alzheimer's disease: just multiple pathologies or partners in crime?
    Brain. 2021;144:706-708.
    >> Share


  21. Corrigendum to: Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2021 Apr 6. pii: 6213355. doi: 10.1093.
    >> Share

    March 2021
  22. RAJNA Z, Mattila H, Huotari N, Tuovinen T, et al
    Cardiovascular brain impulses in Alzheimer's disease.
    Brain. 2021 Mar 31. pii: 6206368. doi: 10.1093.
    >> Share

  23. YAP SY, Frias B, Wren MC, Scholl M, et al
    Discriminatory ability of next-generation tau PET tracers for Alzheimer's disease.
    Brain. 2021 Mar 20. pii: 6179104. doi: 10.1093.
    >> Share

  24. EWERS M, Luan Y, Frontzkowski L, Neitzel J, et al
    Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6174116. doi: 10.1093.
    >> Share

  25. ASBY D, Boche D, Allan S, Love S, et al
    Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
    Brain. 2021 Mar 16. pii: 6173392. doi: 10.1093.
    >> Share

  26. SPINA S, La Joie R, Petersen C, Nolan AL, et al
    Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
    Brain. 2021 Mar 9. pii: 6164966. doi: 10.1093.
    >> Share

  27. HUSAIN M
    Blood tests to screen for Alzheimer's disease.
    Brain. 2021;144:355-356.
    >> Share

  28. KIM JH, Afridi R, Han J, Jung HG, et al
    Gamma subunit of complement component 8 is a neuroinflammation inhibitor.
    Brain. 2021;144:528-552.
    >> Share

    February 2021
  29. JAGUST W
    Integrating events in the disintegration of Alzheimer's disease.
    Brain. 2021;144:11-14.
    >> Share

  30. TIJMS BM, Teunissen CE
    Concatenating plasma p-tau to Alzheimer's disease.
    Brain. 2021;144:14-17.
    >> Share

    January 2021
  31. KESHAVAN A, Pannee J, Karikari TK, Rodriguez JL, et al
    Population-based blood screening for preclinical Alzheimer's disease in a British birth cohort at age 70.
    Brain. 2021 Jan 22. pii: 6105867. doi: 10.1093.
    >> Share


  32. Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2021 Jan 12. pii: 6091150. doi: 10.1093.
    >> Share

    December 2020
  33. JOHNSON JCS, Marshall CR, Weil RS, Bamiou DE, et al
    Hearing and dementia: from ears to brain.
    Brain. 2020 Dec 22. pii: 6044086. doi: 10.1093.
    >> Share

  34. MONTERO-CRESPO M, Dominguez-Alvaro M, Alonso-Nanclares L, DeFelipe J, et al
    Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.
    Brain. 2020 Dec 16. pii: 6038920. doi: 10.1093.
    >> Share

  35. HORIE K, Barthelemy NR, Sato C, Bateman RJ, et al
    CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease.
    Brain. 2020 Dec 7. pii: 6024973. doi: 10.1093.
    >> Share

  36. TEUNISSEN CE, Thijssen EH, Verberk IMW
    Plasma p-tau217: from 'new kid' to most promising candidate for Alzheimer's disease blood test.
    Brain. 2020;143:3170-3172.
    >> Share

  37. PEREIRA JB, Janelidze S, Ossenkoppele R, Kvartsberg H, et al
    Untangling the association of amyloid-beta and tau with synaptic and axonal loss in Alzheimer's disease.
    Brain. 2020 Dec 5. pii: 6024803. doi: 10.1093.
    >> Share

  38. TIJMS BM, Gobom J, Reus L, Jansen I, et al
    Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
    Brain. 2020;143:3776-3792.
    >> Share

  39. SMITH R, Strandberg O, Mattsson-Carlgren N, Leuzy A, et al
    The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Brain. 2020;143:3805-3815.
    >> Share

  40. FLORES-AGUILAR L, Iulita MF, Kovecses O, Torres MD, et al
    Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Brain. 2020;143:3653-3671.
    >> Share

    November 2020
  41. MOSCOSO A, Grothe MJ, Ashton NJ, Karikari TK, et al
    Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
    Brain. 2020 Nov 30. pii: 6012955. doi: 10.1093.
    >> Share

  42. BRIER MR, Day GS
    Serum neurofilament light chain uncovers neurodegeneration early in the course of Alzheimer's disease.
    Brain. 2020 Nov 30. pii: 6012788. doi: 10.1093.
    >> Share

  43. SUR C, Kost J, Scott D, Adamczuk K, et al
    BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
    Brain. 2020 Nov 30. pii: 6012787. doi: 10.1093.
    >> Share

  44. RUAN Z, Pathak D, Venkatesan Kalavai S, Yoshii-Kitahara A, et al
    Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
    Brain. 2020 Nov 27. pii: 6007752. doi: 10.1093.
    >> Share

  45. BENEDET AL, Leuzy A, Pascoal TA, Ashton NJ, et al
    Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Brain. 2020 Nov 19. pii: 5990278. doi: 10.1093.
    >> Share

  46. JIA L, Li F, Wei C, Zhu M, et al
    Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.
    Brain. 2020 Nov 14. pii: 5981992. doi: 10.1093.
    >> Share

  47. LIU KY, Reeves S, McAleese KE, Attems J, et al
    Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.
    Brain. 2020 Nov 14. pii: 5981742. doi: 10.1093.
    >> Share

  48. JI X, Liu G
    rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974904. doi: 10.1093.
    >> Share

  49. DUMITRESCU L, Hohman TJ
    Reply: rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences.
    Brain. 2020 Nov 11. pii: 5974883. doi: 10.1093.
    >> Share

  50. JOSEPHS KA, Martin PR, Weigand SD, Tosakulwong N, et al
    Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Brain. 2020 Nov 5. pii: 5956321. doi: 10.1093.
    >> Share

  51. SOLEIMANI-MEIGOONI DN, Iaccarino L, La Joie R, Baker S, et al
    18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Brain. 2020 Nov 3. pii: 5952719. doi: 10.1093.
    >> Share

    October 2020
  52. MATTSSON-CARLGREN N, Janelidze S, Palmqvist S, Cullen N, et al
    Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
    Brain. 2020 Oct 17. pii: 5929275. doi: 10.1093.
    >> Share

    September 2020
  53. FORSBERG MOREN A, Varrone A
    Timing is everything: tau imaging across stages of Alzheimer's disease.
    Brain. 2020;143:2634-2636.
    >> Share

  54. HARDY CJD, Yong KXX, Goll JC, Crutch SJ, et al
    Impairments of auditory scene analysis in posterior cortical atrophy.
    Brain. 2020 Sep 1. pii: 5900355. doi: 10.1093.
    >> Share

    August 2020
  55. HORSAGER J, Andersen KB, Knudsen K, Skjaerbaek C, et al
    Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
    Brain. 2020 Aug 24. pii: 5896254. doi: 10.1093.
    >> Share

  56. DRUMMOND E, Pires G, MacMurray C, Askenazi M, et al
    Phosphorylated tau interactome in the human Alzheimer's disease brain.
    Brain. 2020 Aug 19. pii: 5893817. doi: 10.1093.
    >> Share

  57. DUMITRESCU L, Mahoney ER, Mukherjee S, Lee ML, et al
    Genetic variants and functional pathways associated with resilience to Alzheimer's disease.
    Brain. 2020;143:2561-2575.
    >> Share

    July 2020
  58. HARRISON IF, Ismail O, Machhada A, Colgan N, et al
    Impaired glymphatic function and clearance of tau in an Alzheimer's disease model.
    Brain. 2020 Jul 23. pii: 5875735. doi: 10.1093.
    >> Share

  59. PASCOAL TA, Therriault J, Benedet AL, Savard M, et al
    18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Brain. 2020 Jul 16. pii: 5872095. doi: 10.1093.
    >> Share

  60. COUSINS KAQ, Irwin DJ, Wolk DA, Lee EB, et al
    ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration.
    Brain. 2020;143:2295-2311.
    >> Share

    June 2020
  61. FAN CC, Banks SJ, Thompson WK, Chen CH, et al
    Sex-dependent autosomal effects on clinical progression of Alzheimer's disease.
    Brain. 2020 Jun 27. pii: 5863662. doi: 10.1093.
    >> Share

  62. SINTINI I, Graff-Radford J, Senjem ML, Schwarz CG, et al
    Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
    Brain. 2020 Jun 23. pii: 5861030. doi: 10.1093.
    >> Share

  63. PRZYBYLA M, van Eersel J, van Hummel A, van der Hoven J, et al
    Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Brain. 2020;143:1889-1904.
    >> Share

    May 2020
  64. ARENA JD, Smith DH, Lee EB, Gibbons GS, et al
    Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.
    Brain. 2020 May 11. pii: 5835545. doi: 10.1093.
    >> Share

  65. MALPETTI M, Kievit RA, Passamonti L, Jones PS, et al
    Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Brain. 2020 May 7. pii: 5831943. doi: 10.1093.
    >> Share

  66. QIU S, Joshi PS, Miller MI, Xue C, et al
    Development and validation of an interpretable deep learning framework for Alzheimer's disease classification.
    Brain. 2020 May 1. pii: 5827821. doi: 10.1093.
    >> Share

    April 2020
  67. SPOTORNO N, Acosta-Cabronero J, Stomrud E, Lampinen B, et al
    Relationship between cortical iron and tau aggregation in Alzheimer's disease.
    Brain. 2020 Apr 24. pii: 5824902. doi: 10.1093.
    >> Share

  68. BERRON D, van Westen D, Ossenkoppele R, Strandberg O, et al
    Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease.
    Brain. 2020 Apr 6. pii: 5816707. doi: 10.1093.
    >> Share

  69. VELDSMAN M
    Atrophy network mapping of transdiagnostic cognitive and neuropsychiatric symptoms.
    Brain. 2020;143:1053-1056.
    >> Share

  70. DE WOLF F, Ghanbari M, Licher S, McRae-McKee K, et al
    Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study.
    Brain. 2020;143:1220-1232.
    >> Share

    March 2020
  71. TETREAULT AM, Phan T, Orlando D, Lyu I, et al
    Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease.
    Brain. 2020 Mar 16. pii: 5807900. doi: 10.1093.
    >> Share

  72. FERNANDEZ-CABELLO S, Kronbichler M, Van Dijk KRA, Goodman JA, et al
    Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
    Brain. 2020;143:993-1009.
    >> Share

  73. AGOSTA F, Canu E, Filippi M
    Virtual reality and real-time neurofeedback functional MRI: a breakthrough in foreseeing Alzheimer's disease?
    Brain. 2020;143:722-726.
    >> Share

  74. SKOURAS S, Torner J, Andersson P, Koush Y, et al
    Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
    Brain. 2020;143:976-992.
    >> Share

    February 2020
  75. NELSON PT
    Reply: Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.
    Brain. 2020 Feb 4. pii: 5722221. doi: 10.1093.
    >> Share

  76. TORRES P, Andres-Benito P, Fernandez-Bernal A, Ricart M, et al
    Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.
    Brain. 2020 Feb 4. pii: 5722222. doi: 10.1093.
    >> Share

  77. PICHET BINETTE A, Gonneaud J, Vogel JW, La Joie R, et al
    Morphometric network differences in ageing versus Alzheimer's disease dementia.
    Brain. 2020;143:635-649.
    >> Share

  78. ITURRIA-MEDINA Y, Khan AF, Adewale Q, Shirazi AH, et al
    Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration.
    Brain. 2020;143:661-673.
    >> Share

  79. TEYLAN M, Mock C, Gauthreaux K, Chen YC, et al
    Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.
    Brain. 2020;143:611-621.
    >> Share

    January 2020
  80. ROBINSON JL, Richardson H, Xie SX, Suh E, et al
    The development and convergence of co-pathologies in Alzheimer's disease.
    Brain. 2020 Jan 15. pii: 6101614. doi: 10.1093.
    >> Share

  81. BETTHAUSER TJ, Koscik RL, Jonaitis EM, Allison SL, et al
    Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
    Brain. 2020;143:320-335.
    >> Share

  82. ROWE J
    Editorial.
    Brain. 2020;143:1.
    >> Share

    December 2019
  83. BADHWAR A, McFall GP, Sapkota S, Black SE, et al
    A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.
    Brain. 2019 Dec 31. pii: 5692271. doi: 10.1093.
    >> Share

  84. GOURMAUD S, Shou H, Irwin DJ, Sansalone K, et al
    Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.
    Brain. 2019 Dec 13. pii: 5675543. doi: 10.1093.
    >> Share

  85. BLENNOW K, Chen C, Cicognola C, Wildsmith KR, et al
    Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.
    Brain. 2019 Dec 13. pii: 5675540. doi: 10.1093.
    >> Share

  86. KORONYO-HAMAOUI M, Sheyn J, Hayden EY, Li S, et al
    Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
    Brain. 2019 Dec 3. pii: 5651064. doi: 10.1093.
    >> Share

    November 2019
  87. MORRONE CD, Bazzigaluppi P, Beckett TL, Hill ME, et al
    Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-beta attenuation.
    Brain. 2019 Nov 28. pii: 5647334. doi: 10.1093.
    >> Share

  88. YOUNAN D, Petkus AJ, Widaman KF, Wang X, et al
    Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.
    Brain. 2019 Nov 20. pii: 5628036. doi: 10.1093.
    >> Share

    October 2019
  89. LIU G, Zhang H, Liu B, Ji X, et al
    Rs2293871 regulates HTRA1 expression and affects cerebral small vessel stroke and Alzheimer's disease.
    Brain. 2019 Oct 11. pii: 5585665. doi: 10.1093.
    >> Share

  90. ZHANG M, Dilliott AA, Khallaf R, Robinson JF, et al
    Genetic and epigenetic study of an Alzheimer's disease family with monozygotic triplets.
    Brain. 2019 Oct 3. pii: 5580538. doi: 10.1093.
    >> Share

    September 2019
  91. TAKAHATA K, Kimura Y, Sahara N, Koga S, et al
    PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury.
    Brain. 2019 Sep 2. pii: 5556830. doi: 10.1093.
    >> Share

  92. DUMITRESCU L, Barnes LL, Thambisetty M, Beecham G, et al
    Sex differences in the genetic predictors of Alzheimer's pathology.
    Brain. 2019;142:2581-2589.
    >> Share

    August 2019
  93. PANZA F, Lozupone M, Solfrizzi V, Watling M, et al
    Time to test antibacterial therapy in Alzheimer's disease.
    Brain. 2019 Aug 29. pii: 5556366. doi: 10.1093.
    >> Share

    July 2019
  94. OVERK C, Masliah E
    Could changing the course of Alzheimer's disease pathology with immunotherapy prevent dementia?
    Brain. 2019;142:1853-1855.
    >> Share

    June 2019
  95. GAUBERT S, Raimondo F, Houot M, Corsi MC, et al
    EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
    Brain. 2019 Jun 18. pii: 5519996. doi: 10.1093.
    >> Share

  96. MAASS A, Berron D, Harrison TM, Adams JN, et al
    Alzheimer's pathology targets distinct memory networks in the ageing brain.
    Brain. 2019 Jun 14. pii: 5519092. doi: 10.1093.
    >> Share

  97. NICOLL JAR, Buckland GR, Harrison CH, Page A, et al
    Persistent neuropathological effects 14 years following amyloid-beta immunization in Alzheimer's disease.
    Brain. 2019 Jun 3. pii: 5510133. doi: 10.1093.
    >> Share

  98. PHILLIPS JS, Da Re F, Irwin DJ, McMillan CT, et al
    Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.
    Brain. 2019;142:1701-1722.
    >> Share

  99. JEGANATHAN J, Breakspear M
    Are the 'atoms of thought' longer in Lewy body dementia?
    Brain. 2019;142:1494-1497.
    >> Share

  100. HOWETT D, Castegnaro A, Krzywicka K, Hagman J, et al
    Differentiation of mild cognitive impairment using an entorhinal cortex-based test of virtual reality navigation.
    Brain. 2019;142:1751-1766.
    >> Share

  101. NELSON PT, Dickson DW, Trojanowski JQ, Jack CR, et al
    Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
    Brain. 2019;142:1503-1527.
    >> Share

  102. ALBERT M, Mairet-Coello G, Danis C, Lieger S, et al
    Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Brain. 2019;142:1736-1750.
    >> Share

  103. SCHUMACHER J, Peraza LR, Firbank M, Thomas AJ, et al
    Dysfunctional brain dynamics and their origin in Lewy body dementia.
    Brain. 2019;142:1767-1782.
    >> Share

    May 2019
  104. BRINKMALM G, Hong W, Wang Z, Liu W, et al
    Identification of neurotoxic cross-linked amyloid-beta dimers in the Alzheimer's brain.
    Brain. 2019;142:1441-1457.
    >> Share

  105. BATEMAN RJ, Mawuenyega KG, Wildburger NC
    The structure of amyloid-beta dimers in Alzheimer's disease brain: a step forward for oligomers.
    Brain. 2019;142:1168-1169.
    >> Share

    April 2019
  106. PONTECORVO MJ, Devous MD, Kennedy I, Navitsky M, et al
    A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Brain. 2019 Apr 22. pii: 5476105. doi: 10.1093.
    >> Share

  107. LYON L
    Is an epidemic of sleeplessness increasing the incidence of Alzheimer's disease?
    Brain. 2019 Apr 1. pii: 5425265. doi: 10.1093.
    >> Share

  108. ILLAN-GALA I, Montal V, Borrego-Ecija S, Vilaplana E, et al
    Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.
    Brain. 2019;142:1121-1133.
    >> Share

  109. KNOPMAN DS, Lundt ES, Therneau TM, Vemuri P, et al
    Entorhinal cortex tau, amyloid-beta, cortical thickness and memory performance in non-demented subjects.
    Brain. 2019;142:1148-1160.
    >> Share

    March 2019
  110. VOGLEIN J, Paumier K, Jucker M, Preische O, et al
    Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease.
    Brain. 2019 Mar 20. pii: 5416202. doi: 10.1093.
    >> Share

  111. ARENAZA-URQUIJO EM, Przybelski SA, Lesnick TL, Graff-Radford J, et al
    The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
    Brain. 2019 Mar 8. pii: 5372751. doi: 10.1093.
    >> Share

    February 2019
  112. YAMAZAKI Y, Shinohara M, Shinohara M, Yamazaki A, et al
    Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression.
    Brain. 2019 Feb 15. pii: 5321132. doi: 10.1093.
    >> Share

  113. FRANZMEIER N, Rubinski A, Neitzel J, Kim Y, et al
    Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease.
    Brain. 2019 Feb 15. pii: 5321130. doi: 10.1093.
    >> Share

  114. GORDON BA, Blazey TM, Christensen J, Dincer A, et al
    Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Brain. 2019 Feb 11. pii: 5315649. doi: 10.1093.
    >> Share

  115. TAN CH, Bonham LW, Fan CC, Mormino EC, et al
    Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.
    Brain. 2019;142:460-470.
    >> Share

  116. KULLMANN DM
    Editorial.
    Brain. 2019;142:227.
    >> Share

    January 2019
  117. ZHENG Y, Liu A, Wang ZJ, Cao Q, et al
    Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease.
    Brain. 2019 Jan 22. pii: 5298257. doi: 10.1093.
    >> Share

  118. PARK JC, Han SH, Yi D, Byun MS, et al
    Plasma tau/amyloid-beta1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease.
    Brain. 2019 Jan 21. pii: 5292577. doi: 10.1093.
    >> Share

  119. ZHU BL, Long Y, Luo W, Yan Z, et al
    MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation.
    Brain. 2019;142:176-192.
    >> Share

  120. POWER MC
    Growing evidence links air pollution exposure to risk of Alzheimer's disease and related dementia.
    Brain. 2019;143:8-10.
    >> Share

    December 2018
  121. DARBY RR, Joutsa J, Fox MD
    Network localization of heterogeneous neuroimaging findings.
    Brain. 2018 Dec 14. pii: 5244188. doi: 10.1093.
    >> Share

  122. KOLANKO MA, Malhotra PA
    Exploring Alzheimer's disease subtypes at the prodromal stage.
    Brain. 2018;141:3285-3287.
    >> Share

    October 2018
  123. TEN KATE M, Dicks E, Visser PJ, van der Flier WM, et al
    Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
    Brain. 2018 Oct 22. pii: 5142624. doi: 10.1093.
    >> Share

  124. JACOBS HIL, Buckley RF
    Where do white matter alterations dovetail with the cascade model of Alzheimer's disease?
    Brain. 2018;141:2830-2833.
    >> Share

    September 2018
  125. ARAQUE CABALLERO MA, Suarez-Calvet M, Duering M, Franzmeier N, et al
    White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease.
    Brain. 2018 Sep 19. pii: 5104289. doi: 10.1093.
    >> Share

    August 2018
  126. PETYUK VA, Chang R, Ramirez-Restrepo M, Beckmann ND, et al
    The human brainome: network analysis identifies HSPA2 as a novel Alzheimer's disease target.
    Brain. 2018 Aug 20. pii: 5077110. doi: 10.1093.
    >> Share

  127. GAO S, Casey AE, Sargeant TJ, Makinen VP, et al
    Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.
    Brain. 2018 Aug 16. pii: 5075310. doi: 10.1093.
    >> Share

  128. GAUTHIER S, Herrmann N, Rosa-Neto P
    Optimal use of cholinergic drugs in Alzheimer's disease.
    Brain. 2018 Aug 2. pii: 5064194. doi: 10.1093.
    >> Share

  129. HAMPEL H, Cavedo E, Vergallo A
    Reply: Optimal use of cholinergic drugs in Alzheimer's disease.
    Brain. 2018 Aug 2. pii: 5064191. doi: 10.1093.
    >> Share

  130. SAMI S, Williams N, Hughes LE, Cope TE, et al
    Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype.
    Brain. 2018;141:2500-2510.
    >> Share

    July 2018
  131. DANI M, Wood M, Mizoguchi R, Fan Z, et al
    Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Brain. 2018 Jul 20. pii: 5056962. doi: 10.1093.
    >> Share

  132. GROTHE MJ, Sepulcre J, Gonzalez-Escamilla G, Jelistratova I, et al
    Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
    Brain. 2018 Jul 16. pii: 5054650. doi: 10.1093.
    >> Share

    June 2018
  133. COSTA C, Romoli M, Calabresi P
    Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-beta.
    Brain. 2018 Jun 9. pii: 5035368. doi: 10.1093.
    >> Share

  134. SEN A, Husain M
    Reply: Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-beta.
    Brain. 2018 Jun 9. pii: 5035367. doi: 10.1093.
    >> Share

  135. TIJMS BM, Visser PJ
    Chasing the start of sporadic Alzheimer's disease running in families.
    Brain. 2018;141:1589-1591.
    >> Share

    May 2018
  136. SCELSI MA, Khan RR, Lorenzi M, Christopher L, et al
    Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci.
    Brain. 2018 May 30. pii: 5025682. doi: 10.1093.
    >> Share

  137. HAMPEL H, Mesulam MM, Cuello AC, Farlow MR, et al
    The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
    Brain. 2018 May 29. pii: 5023826. doi: 10.1093.
    >> Share

  138. LI D, Donohue MC
    Disease progression models for dominantly-inherited Alzheimer's disease.
    Brain. 2018;141:1244-1246.
    >> Share

  139. HANSSON O, Mormino EC
    Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials?
    Brain. 2018;141:1241-1244.
    >> Share

    April 2018
  140. VOGEL JW, Vachon-Presseau E, Pichet Binette A, Tam A, et al
    Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.
    Brain. 2018 Apr 23. pii: 4969934. doi: 10.1093.
    >> Share

  141. SABRI O, Meyer PM, Graf S, Hesse S, et al
    Cognitive correlates of alpha4beta2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Brain. 2018 Apr 17. pii: 4974320. doi: 10.1093.
    >> Share

  142. MISHRA S, Blazey TM, Holtzman DM, Cruchaga C, et al
    Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE varepsilon4 genotype.
    Brain. 2018 Apr 17. pii: 4974818. doi: 10.1093.
    >> Share

  143. MCALEESE KE, Walker L, Colloby SJ, Taylor JP, et al
    Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease?
    Brain. 2018 Apr 13. pii: 4969931. doi: 10.1093.
    >> Share

  144. MITO R, Raffelt D, Dhollander T, Vaughan DN, et al
    Reply: Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease?
    Brain. 2018 Apr 13. pii: 4969932. doi: 10.1093.
    >> Share

    March 2018
  145. HAMELIN L, Lagarde J, Dorothee G, Potier MC, et al
    Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease.
    Brain. 2018 Mar 28. pii: 4955843. doi: 10.1093.
    >> Share

  146. OXTOBY NP, Young AL, Cash DM, Benzinger TLS, et al
    Data-driven models of dominantly-inherited Alzheimer's disease progression.
    Brain. 2018 Mar 22. pii: 4951528. doi: 10.1093.
    >> Share

  147. JACK CR JR, Wiste HJ, Schwarz CG, Lowe VJ, et al
    Longitudinal tau PET in ageing and Alzheimer's disease.
    Brain. 2018 Mar 12. pii: 4929907. doi: 10.1093.
    >> Share

  148. CHHATWAL JP, Schultz AP, Johnson KA, Hedden T, et al
    Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.
    Brain. 2018 Mar 7. pii: 4924520. doi: 10.1093.
    >> Share

  149. NAKAMURA A, Cuesta P, Fernandez A, Arahata Y, et al
    Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.
    Brain. 2018 Mar 7. pii: 4924218. doi: 10.1093.
    >> Share

  150. SULTZER DL
    Cognitive ageing and Alzheimer's disease: the cholinergic system redux.
    Brain. 2018;141:626-628.
    >> Share

    February 2018
  151. FRANZMEIER N, Duzel E, Jessen F, Buerger K, et al
    Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
    Brain. 2018 Feb 15. pii: 4862492. doi: 10.1093.
    >> Share

  152. WHITWELL JL
    Multimodal neuroimaging provides insights into the biology of Alzheimer's disease.
    Brain. 2018;141:326-329.
    >> Share

    January 2018
  153. HOENIG MC, Bischof GN, Seemiller J, Hammes J, et al
    Networks of tau distribution in Alzheimer's disease.
    Brain. 2018 Jan 5. pii: 4791255. doi: 10.1093.
    >> Share

  154. RICHTER N, Beckers N, Onur OA, Dietlein M, et al
    Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.
    Brain. 2018 Jan 4. pii: 4788772. doi: 10.1093.
    >> Share

  155. MITO R, Raffelt D, Dhollander T, Vaughan DN, et al
    Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Brain. 2018 Jan 4. pii: 4788771. doi: 10.1093.
    >> Share

  156. HERHOLZ K
    Spread of tau deposits: can we trust in vivo findings?
    Brain. 2018;141:10-12.
    >> Share

  157. GRATWICKE JP, Foltynie T
    Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson's disease.
    Brain. 2018;141:7-10.
    >> Share

    December 2017
  158. COPE TE, Rittman T, Borchert RJ, Jones PS, et al
    Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Brain. 2017 Dec 26. pii: 4775021. doi: 10.1093.
    >> Share

  159. MAEZAWA I, Nguyen HM, Di Lucente J, Jenkins DP, et al
    Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Brain. 2017 Dec 18. pii: 4759461. doi: 10.1093.
    >> Share

  160. LOWE VJ, Wiste HJ, Senjem ML, Weigand SD, et al
    Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
    Brain. 2017 Dec 8. pii: 4712020. doi: 10.1093.
    >> Share

  161. FRANZMEIER N, Dyrba M
    Functional brain network architecture may route progression of Alzheimer's disease pathology.
    Brain. 2017;140:3077-3080.
    >> Share

  162. MUTLU J, Landeau B, Gaubert M, de La Sayette V, et al
    Distinct influence of specific versus global connectivity on the different Alzheimer's disease biomarkers.
    Brain. 2017;140:3317-3328.
    >> Share

  163. COLOM-CADENA M, Pegueroles J, Herrmann AG, Henstridge CM, et al
    Synaptic phosphorylated alpha-synuclein in dementia with Lewy bodies.
    Brain. 2017;140:3204-3214.
    >> Share

  164. SANTAMARIA-GARCIA H, Baez S, Reyes P, Santamaria-Garcia JA, et al
    A lesion model of envy and Schadenfreude: legal, deservingness and moral dimensions as revealed by neurodegeneration.
    Brain. 2017;140:3357-3377.
    >> Share

  165. PERRY DC, Brown JA, Possin KL, Datta S, et al
    Clinicopathological correlations in behavioural variant frontotemporal dementia.
    Brain. 2017;140:3329-3345.
    >> Share

  166. RODRIGUEZ-RODRIGUEZ P, Sandebring-Matton A, Merino-Serrais P, Parrado-Fernandez C, et al
    Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons.
    Brain. 2017;140:3269-3285.
    >> Share

    November 2017
  167. SHINOHARA M, Koga S, Konno T, Nix J, et al
    Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-beta42 in Alzheimer's disease.
    Brain. 2017 Nov 17. doi: 10.1093.
    >> Share

  168. BUSTOS FJ, Ampuero E, Jury N, Aguilar R, et al
    Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer's disease mice.
    Brain. 2017 Nov 16. doi: 10.1093.
    >> Share

  169. GRINBERG LT, Heinsen H
    Light at the beginning of the tunnel? Investigating early mechanistic changes in Alzheimer's disease.
    Brain. 2017;140:2770-2773.
    >> Share

    October 2017
  170. DU F, Yu Q, Yan S, Hu G, et al
    PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.
    Brain. 2017 Oct 25. doi: 10.1093.
    >> Share

  171. BEJANIN A, Schonhaut DR, La Joie R, Kramer JH, et al
    Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
    Brain. 2017 Oct 7. doi: 10.1093.
    >> Share

    September 2017
  172. RORABAUGH JM, Chalermpalanupap T, Botz-Zapp CA, Fu VM, et al
    Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Brain. 2017 Sep 25. doi: 10.1093.
    >> Share

  173. CHONG JSX, Liu S, Loke YM, Hilal S, et al
    Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer's disease.
    Brain. 2017 Sep 19. doi: 10.1093.
    >> Share

  174. SCHOLL M, Ossenkoppele R, Strandberg O, Palmqvist S, et al
    Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
    Brain. 2017;140:2286-2294.
    >> Share

    August 2017
  175. DERRY PJ, Kent TA
    Correlating quantitative susceptibility mapping with cognitive decline in Alzheimer's disease.
    Brain. 2017;140:2069-2072.
    >> Share

  176. KIM H, Yoo J, Shin J, Chang Y, et al
    Modelling APOE varepsilon3/4 allele-associated sporadic Alzheimer's disease in an induced neuron.
    Brain. 2017;140:2193-2209.
    >> Share

  177. AYTON S, Fazlollahi A, Bourgeat P, Raniga P, et al
    Cerebral quantitative susceptibility mapping predicts amyloid-beta-related cognitive decline.
    Brain. 2017;140:2112-2119.
    >> Share

    July 2017
  178. JACOBS HIL, Hopkins DA, Mayrhofer HC, Bruner E, et al
    The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline.
    Brain. 2017 Jul 28. doi: 10.1093.
    >> Share

  179. YEW B, Nation DA
    Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Brain. 2017;140:1987-2001.
    >> Share

  180. MARKUS HS
    Cerebrovascular abnormalities in Alzheimer's dementia: a more tractable treatment target?
    Brain. 2017;140:1822-1825.
    >> Share

  181. KREISL WC
    Discerning the relationship between microglial activation and Alzheimer's disease.
    Brain. 2017;140:1825-1828.
    >> Share

    June 2017
  182. GEORGE C, Gontier G, Lacube P, Francois JC, et al
    The Alzheimer's disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons.
    Brain. 2017 Jun 8. doi: 10.1093.
    >> Share

    May 2017
  183. PARBO P, Ismail R, Hansen KV, Amidi A, et al
    Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease.
    Brain. 2017 May 28. doi: 10.1093.
    >> Share

  184. DANSOKHO C, Aucouturier P, Dorothee G
    Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.
    Brain. 2017 May 12. doi: 10.1093.
    >> Share

  185. ALVES S, Churlaud G, Klatzmann D, Cartier N, et al
    Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.
    Brain. 2017 May 12. doi: 10.1093.
    >> Share

  186. TOSUN D, Landau S, Aisen PS, Petersen RC, et al
    Association between tau deposition and antecedent amyloid-beta accumulation rates in normal and early symptomatic individuals.
    Brain. 2017;140:1499-1512.
    >> Share

    April 2017
  187. HARDY J, De Strooper B
    Alzheimer's disease: where next for anti-amyloid therapies?
    Brain. 2017;140:853-855.
    >> Share

  188. CARAVAGGIO F, Graff-Guerrero A
    Is antipsychotic sensitivity in Alzheimer's disease secondary to abnormal blood-brain barrier integrity?
    Brain. 2017;140:865-867.
    >> Share

    March 2017
  189. YU M, Engels MM, Hillebrand A, van Straaten EC, et al
    Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.
    Brain. 2017 Mar 16. doi: 10.1093.
    >> Share

  190. ROBERTS BR, Lind M, Wagen AZ, Rembach A, et al
    Biochemically-defined pools of amyloid-beta in sporadic Alzheimer's disease: correlation with amyloid PET.
    Brain. 2017 Mar 5. doi: 10.1093.
    >> Share

  191. COULTHARD E, Knight M
    Refining Alzheimer's disease diagnosis with MRI.
    Brain. 2017;140:524-526.
    >> Share

    February 2017
  192. BANERJEE G, Kim HJ, Fox Z, Jager HR, et al
    MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
    Brain. 2017 Feb 17. doi: 10.1093.
    >> Share

  193. REEVES S, McLachlan E, Bertrand J, Antonio FD, et al
    Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.
    Brain. 2017 Feb 4. doi: 10.1093.
    >> Share

  194. HUSAIN M
    Alzheimer's disease: time to focus on the brain, not just molecules.
    Brain. 2017;140.
    >> Share

    January 2017
  195. PASSAMONTI L, Vazquez Rodriguez P, Hong YT, Allinson KS, et al
    18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
    Brain. 2017 Jan 24. pii: aww340. doi: 10.1093.
    >> Share

  196. FAN Z, Brooks DJ, Okello A, Edison P, et al
    An early and late peak in microglial activation in Alzheimer's disease trajectory.
    Brain. 2017 Jan 24. pii: aww349. doi: 10.1093.
    >> Share

  197. HAYES JP, Logue MW, Sadeh N, Spielberg JM, et al
    Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
    Brain. 2017 Jan 11. pii: aww344. doi: 10.1093.
    >> Share

  198. PONTECORVO MJ, Devous MD Sr, Navitsky M, Lu M, et al
    Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Brain. 2017 Jan 11. pii: aww334. doi: 10.1093.
    >> Share

  199. CAPSONI S, Malerba F, Carucci NM, Rizzi C, et al
    The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor.
    Brain. 2017;140.
    >> Share

  200. AHMED RM, Landin-Romero R, Collet TH, van der Klaauw AA, et al
    Energy expenditure in frontotemporal dementia: a behavioural and imaging study.
    Brain. 2017;140.
    >> Share

    December 2016
  201. ALVES S, Churlaud G, Audrain M, Michaelsen-Preusse K, et al
    Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
    Brain. 2016 Dec 20. pii: aww330. doi: 10.1093.
    >> Share

  202. DONG A, Toledo JB, Honnorat N, Doshi J, et al
    Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.
    Brain. 2016 Dec 20. pii: aww319. doi: 10.1093.
    >> Share

    October 2016
  203. ROGAEVA E, Schmitt-Ulms G
    Does BDNF Val66Met contribute to preclinical Alzheimer's disease?
    Brain. 2016;139.
    >> Share

    September 2016
  204. JAMES BD, Wilson RS, Boyle PA, Trojanowski JQ, et al
    TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    Brain. 2016.
    >> Share

    March 2016
  205. SCHWARZ AJ, Yu P, Miller BB, Shcherbinin S, et al
    Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Brain. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016